1 | basis | 12,892 |
2 | underpinnings | 129 |
3 | substratum | 25 |
4 | preselection | 13 |
5 | crossroad | 5 |
6 | fundament | 5 |
7 | mrw | 5 |
8 | c-region | 4 |
9 | contractor | 4 |
10 | insyte | 3 |
11 | lidt | 3 |
12 | af-clinic | 2 |
13 | caracteristics | 2 |
14 | crafft | 2 |
15 | de-phosphorylation | 2 |
16 | delphi-list | 2 |
17 | heterooligomerization | 2 |
18 | meta-position | 2 |
19 | monomax® | 2 |
20 | nonutilization | 2 |
21 | ph-range | 2 |
22 | re-orientation | 2 |
23 | riches | 2 |
24 | scrivener | 2 |
25 | sensitivities/specificities | 2 |
26 | space-time-yield | 2 |
27 | analyses-assumption | 1 |
28 | certificates.out | 1 |
29 | immuno-neuro-endocrine | 1 |
30 | lifestyle-lessons | 1 |
31 | maturity-and | 1 |
32 | mmitt | 1 |
33 | n=5531 | 1 |
34 | narrower/higher | 1 |
35 | noncarrying | 1 |
36 | pharmacokinetics-evaluable | 1 |
37 | study/data | 1 |
38 | target/response | 1 |
39 | therapyrecommendations | 1 |
40 | thermal-response | 1 |
41 | time-since-diagnosis | 1 |
42 | visits/number | 1 |
1 | af-clinic | 2 |
2 | analyses-assumption | 1 |
3 | basis | 12,892 |
4 | c-region | 4 |
5 | caracteristics | 2 |
6 | certificates.out | 1 |
7 | contractor | 4 |
8 | crafft | 2 |
9 | crossroad | 5 |
10 | de-phosphorylation | 2 |
11 | delphi-list | 2 |
12 | fundament | 5 |
13 | heterooligomerization | 2 |
14 | immuno-neuro-endocrine | 1 |
15 | insyte | 3 |
16 | lidt | 3 |
17 | lifestyle-lessons | 1 |
18 | maturity-and | 1 |
19 | meta-position | 2 |
20 | mmitt | 1 |
21 | monomax® | 2 |
22 | mrw | 5 |
23 | n=5531 | 1 |
24 | narrower/higher | 1 |
25 | noncarrying | 1 |
26 | nonutilization | 2 |
27 | ph-range | 2 |
28 | pharmacokinetics-evaluable | 1 |
29 | preselection | 13 |
30 | re-orientation | 2 |
31 | riches | 2 |
32 | scrivener | 2 |
33 | sensitivities/specificities | 2 |
34 | space-time-yield | 2 |
35 | study/data | 1 |
36 | substratum | 25 |
37 | target/response | 1 |
38 | therapyrecommendations | 1 |
39 | thermal-response | 1 |
40 | time-since-diagnosis | 1 |
41 | underpinnings | 129 |
42 | visits/number | 1 |
1 | n=5531 | 1 |
2 | study/data | 1 |
3 | af-clinic | 2 |
4 | crossroad | 5 |
5 | space-time-yield | 2 |
6 | maturity-and | 1 |
7 | ph-range | 2 |
8 | pharmacokinetics-evaluable | 1 |
9 | immuno-neuro-endocrine | 1 |
10 | thermal-response | 1 |
11 | target/response | 1 |
12 | insyte | 3 |
13 | noncarrying | 1 |
14 | substratum | 25 |
15 | c-region | 4 |
16 | de-phosphorylation | 2 |
17 | re-orientation | 2 |
18 | nonutilization | 2 |
19 | heterooligomerization | 2 |
20 | preselection | 13 |
21 | meta-position | 2 |
22 | analyses-assumption | 1 |
23 | visits/number | 1 |
24 | narrower/higher | 1 |
25 | scrivener | 2 |
26 | contractor | 4 |
27 | caracteristics | 2 |
28 | riches | 2 |
29 | sensitivities/specificities | 2 |
30 | underpinnings | 129 |
31 | basis | 12,892 |
32 | time-since-diagnosis | 1 |
33 | therapyrecommendations | 1 |
34 | lifestyle-lessons | 1 |
35 | lidt | 3 |
36 | crafft | 2 |
37 | fundament | 5 |
38 | delphi-list | 2 |
39 | mmitt | 1 |
40 | certificates.out | 1 |
41 | mrw | 5 |
42 | monomax® | 2 |